
|Slideshows|October 9, 2018
- Managed Healthcare Executive November 2018 Issue
- Volume 28
- Issue 11
Eight Top Oncology Drug Approvals
Author(s)Erin Johanek, PharmD, RPh
New cancer drugs continue to offer patients hope. Here are eight of them.
Advertisement
Articles in this issue
about 7 years ago
Looser Restrictions on HRAs on the Horizonover 7 years ago
Nine Ways to Deal with Escalating Drug Costsover 7 years ago
Time to Address ‘Financial Toxicity’ of Cancer Treatmentover 7 years ago
CAR T-cell Therapy: How Payers are Responding to Huge Price Tagsover 7 years ago
Medical Foods Strive for Insurance Coverageover 7 years ago
New Chiefs at MCOs: 4 Positions You May Want to Addover 7 years ago
Eight Predictions for Cancer Care in 10 Yearsover 7 years ago
Is Precision Medicine Worth the Hype? Oncologists Weigh InNewsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
PBM reform. It has finally happened
3
TrumpRx launches; some experts question its long-term value
4
Cancer survival fell and deaths rose during first two years of COVID-19
5

























